The Use of Dialysis and Hemofiltration for Complications of Liver Disease
1998; Wiley; Volume: 11; Issue: 5 Linguagem: Inglês
10.1111/j.1525-139x.1998.tb00374.x
ISSN1525-139X
AutoresGuido O. Pérez, Gabriel Contreras,
Tópico(s)Organ Transplantation Techniques and Outcomes
ResumoSeminars in DialysisVolume 11, Issue 5 p. 308-316 The Use of Dialysis and Hemofiltration for Complications of Liver Disease Guido O. Perez, Corresponding Author Guido O. Perez Department of Medicine, Division of Nephrology, Veterans Affairs Medical Center and University of Miami School of Medicine, Miami, FloridaAddress correspondence to: Guido O. Perez, MD, Dialysis Unit (111C), 1201 NW 16 St Miami, FL 33125Search for more papers by this authorGabriel Contreras, Gabriel Contreras Department of Medicine, Division of Nephrology, Veterans Affairs Medical Center and University of Miami School of Medicine, Miami, FloridaSearch for more papers by this author Guido O. Perez, Corresponding Author Guido O. Perez Department of Medicine, Division of Nephrology, Veterans Affairs Medical Center and University of Miami School of Medicine, Miami, FloridaAddress correspondence to: Guido O. Perez, MD, Dialysis Unit (111C), 1201 NW 16 St Miami, FL 33125Search for more papers by this authorGabriel Contreras, Gabriel Contreras Department of Medicine, Division of Nephrology, Veterans Affairs Medical Center and University of Miami School of Medicine, Miami, FloridaSearch for more papers by this author First published: 01 October 2007 https://doi.org/10.1111/j.1525-139X.1998.tb00374.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Eknoyan G., Martinez-Maldonado M., Yuim JJ, Suki WN: Combined ascitic fluid infusion and furosemide in the management of ascites. N Engl J Med 282: 713–717, 1970. 2 Wilkinson SP, Henderson J., Davidson AR: Ascites reinfusion using the Rhodiascit apparatus—Clinical experience and coagulation abnormalities. Postgrad Med J 51: 583–587, 1975. 3 Lee WM: Management of massive ascites utilizing ascites reinfusion. J Clin Gastroenterol 4: 87–92, 1982. 4 Gines P., Arroyo V., Quintero E., Planas R., Bory F., Cabrera J., Rimola A., Viver J., Camp SJ, Jimenez W.: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: Results of a randomized study. Gastroenterology 93: 234–241, 1987. 5 Smart HL, Triger DR: A randomized prospective trial comparing daily paracentesis and intravenous albumin with recirculation in diuretic refractory ascites. J Hepatol 10: 191–197, 1990. 6 Tito L., Gines P., Arroyo V., Planas R., Panes J., Viver J., Torres M., Humbert P., Rimola A., Llach J., Badalamenti S., Jimenez W., Gaya J., Rodes J.: Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 98: 146–151, 1990. 7 Gines P., Tito L., Arroyo V., Planas R., Panes J., Viver J., Torres M., Humbert P., Rimola A., Llach J., Badalamenti S., Jimenez W., Gaya J., Rodes J.: Randomized comparative study of therapeutic paracentesis with or without intravenous albumin in cirrhosis. Gastroenterology 94: 1493–1502, 1988. 8 Hariprasad MK, Paul PK, Eisinger RP, Gary NE, Timins JE, Miller JW: Extracorporeal dialysis of ascites dialysis in combined hepatic and renal failure: A new technique. Arch Intern Med 141: 1550–1551, 1981. 9 Adler AJ, Feldman J., Friedman EA, Berlyne GM: Use of extracorporeal ascites dialysis of ascites in combined hepatic and renal failure. Nephron 30: 31–35, 1982. 10 Raju SF, Achord JL: The effects of dialytic ultrafiltration and peritoneal reinfusion in the management of diuretic resistant ascites. Am J Gastroenterol 79: 308–312, 1984. 11 Landini S., Coli U., Fracasso A., Morachielo P., Righetto F., Scanferla F., Genchi R., Bazzato G.: Spontaneous ascites filtration and reinfusion (SAFR) in cirrhotic patients. Int J Artif Organs 8: 277–280, 1985. 12 Hariprasad MK, Timins E., Esinger RP, Gary NE: Backflow of albumin from ascites to blood. Dial Transplant 10: 608, 1981. 13 Van Gossum M., Bergmann P., Burelle A., Lemper JC, Dratwa M., Deltenre M.: Evaluation du traitement de l'ascite refractaire par ultrafiltration suivi de reinjection intra-abdominale. Acta Gastroenterol Belg 46: 232–239, 1983. 14 Brendolan A., La Greca G., Fecondini L., Braganiti L., Chiaramonte S., Fabris A., Feriani M., Dal Santo M., D'Alessandro A., Lora A.: New method of extracorporeal concentration of ascitic fluid as a treatment of refractory ascites. Int J Artif Organs 12: 339–344, 1989. 15 Cadranel JF, Gargot D., Grippon P., Lunel F., Bernard B., Valla D., Opolon P.: Spontaneous dialytic ultrafiltration with intraperitoneal reinfusion of the concentrate versus large paracentesis in cirrhotic patients with intractable ascites: A randomized study. Int J Artif Organs 15: 432–435, 1992. 16 Lai KN, Li P., Law E., Swaminathan R., Nicholls MG: Large volume paracentesis versus dialytic ultrafiltration in the treatment of cirrhotic ascites. QJM 78: 33–41, 1991. 17 Bruno S., Borzio M., Romagnoni M., Battezzato PM, Rossi S., Chiesa A., Podda M.: Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites. BMJ 304: 1655–1658, 1992. 18 Lai KN, Leung JW, Swaminathan R., Panesar NS: Treatment of cirrhotic ascites by dialytic ultrafiltration with a hemofilter system. Blood Purif 5: 252–255, 1987. 19 Valbonesi M., Torre GC, Capra C., Frisoni R., Testa R., Zia S., Ferrari M.: Reverse cascade filtration of ascitic fluid—Preliminary results. Int J Artif Organs 11: 134–138, 1988. 20 Landini S., Coli U., Fracasso A., Morachiello P., Righetto F., Scanferla F., Gallenoa F., Bazzato G.: Spontaneous ascites filtration and reinfusion (SAFR) as ambulatory chronic treatment for hepatorenal syndrome. Trans Am Soc Artif Intern Organs 31: 439–443, 1985. 21 Assadi FK, Gordon D., Kecskes SA, John E.: Treatment of refractory ascites by ultrafiltration–reinfusion of ascitic fluid peritoneally. J Pediatr 106: 943–946, 1985. 22 Cadranel JF, Grippon P., Gargot D., Lunel F., Bernard B., Valla D., Opolon P.: Spontaneous dialytic ultrafiltration with intraperitoneal reinfusion of the concentrate in 15 cirrhotic patients with intractable ascites. Int J Artif Organs 15: 168–171, 1992. 23 Brendolan A., Ronco C., Feriani M., Chiaramonte S., Bragantini L., Dal Santo M., Lora L., D'Alessandro A., La Greca G.: Extracorporeal treatment of ascitic fluid and intraperitoneal reinfusion in patients with refractory ascites. Contrib Nephrol 93: 241–244, 1991. 24 Lai KN, Pun CO, Leung JW: Study of hepatic venous wedge and intraperitoneal pressures in cirrhotic patients with refractory ascites treated by dialytic ultrafiltration. J Gastroenterol Hepatol 4: 325–330, 1989. 25 Hwang JC, Chen JA, Fung HY: Hemodialysis alternative with ascites ultrafiltration for an end-stage renal failure patient associated with tense ascites secondary to decompensated liver cirrhosis. Am J Kidney Dis 28: 899–903, 1996. 26 Selgas R., Bajo A., Jimenez C., Sanchez C., Del Peso G., Cacho G., Diaz C., Ferandez-Reyes MJ, DeAlvaro F.: Peritoneal dialysis in liver disorders. Perit Dial Int 16 (Suppl 1): S215–S219, 1996. 27 Franz M., Horl WH: The patient with end-stage renal failure and ascites. Nephrol Dial Transplant 12: 1070–1078, 1997. 28 Kramer P., Wigger W., Rieger J., Matthaei D., Scheler F.: Arteriovenous hemofiltration; a new and simple method for treatment of overhydrated patients, resistant to diuretics. Klin Wochenschrift 55: 1121–1122, 1977. 29 Lauer A., Saccaggi A., Ronco C., Belledonne M., Glabman S., Bosch JP: Continuous arterio-venous-hemofiltration in the critically ill patient: Clinical use and operational characteristics. Ann Intern Med 99: 455–460, 1983. 30 Lauer A., Alvis R., Avram M.: Hemodynamic consequences of continuous arteriovenous hemofiltration. Am J Kidney Dis 12: 110–115, 1988. 31 Epstein M., Perez GO, Bedoya LA, Molina R.: Continuous arteriovenous ultrafiltration in cirrhotic patients with ascites or renal failure. Int J Artif Organs 9: 253–256, 1986. 32 Kaplan AA: Clinical trials with predilution and vacuum suction enhancing the efficiency of the CAVH treatment. Trans Am Soc Artif Intern Organs 32: 49–51, 1986. 33 Hillaire S., Labianca M., Borgonovo G., Smadja C., Grange D., Franco D.: Peritoneovenous shunting of intractable ascites in patients with cirrhosis: Improving results and predictive factors of failure. Surgery 113: 373–379, 1993. 34 Guardiola J., Xiol X., Escriba JM, Castellvi JM, Castellote J., Baliellas C., Rafecas A., Casais LA: Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt. Am J Gastroenterol 90: 2097–2102, 1995. 35 Cattaneo U., Enrico S., Serra GC, Bergoglio D., Corno F., Fronda GR: Refractory ascites: A fifteen-year experience with the peritoneovenous shunt. Minerva Gastroenterologica e Dietologica 39: 119–126, 1993. 36 Zervos EE, McCormick J., Goode SE, Rosemurgy AS: Peritoneovenous shunts in patients with intractable ascites: Palliation at what price Am Surg 63: 157–162, 1997. 37 Elecheroth J., Vons C., Franco D.: Role of surgical therapy in management of intractable ascites. World J Surg 18: 240–245, 1994. 38 Wickremesekera SK, Stubbs RS: Peritoneovenous shunting for malignant ascites. N Z Med J 110: 33–35, 1997. 39 Gandhi VC, Leehey DJ, Stanley MM, Nemchausky BA, Daugirdas JT, Greenlee HB, Jablokow UR, Ing TS: Peritoneo-veno shunting in patients with cirrhotic ascites and end-stage renal failure. Am J Kidney Dis 6: 185–187, 1985. 40 Ochs A., Rossle M., Haag K., Hauenstein KH, Deibert P., Siegerstetter V., Huonker MI, Langer M., Blum H.: The transjugular intrahepatic portosystemic stent–shunt procedure for refractory ascites. N Engl J Med 332: 1192–1197, 1995. 41 Crenshaw WB, Gordon FD, McEniff NJ, Perry LJ, Hartnell G., Anastopoulos H., Jenkins RL, Lewis WD, Wheeler HG, Clouse ME: Severe ascites: Efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 200: 185–192, 1996. 42 Martinet JP, Fenyves D., Legault L., Roy L., Dufresne MP, Spahr L., Lafortune M., Pomier-Layrargues G.: Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): A caution. Dig Dis Sci 42: 161–166, 1997. 43 Fillmore DJ, Miller FJ, Fox LF, Disario JA, Tietze CC: Transjugular intrahepatic portosystemic shunt: Midterm clinical and angiographic follow-up. J Vasc Interv Radiol 7: 255–261, 1996. 44 Linas ST, Schaefer JW, Moore EE, Good JT, Giansiracusa R.: Peritoneovenous shunt in the management of the hepatorenal syndrome. Kidney Int 30: 736–740, 1986. 45 Sturgis TM: Hepatorenal syndrome: Resolution after transjugular intrahepatic portosystemic shunt. J Clin Gastroenterol 20: 241–243, 1995. 46 Gonwa TA, Klintmalm GB, Levy M., Jennings LS, Goldstein RM, Husberg BS: Impact of pretransplant renal function on survival after liver transplantation. Transplant 59: 361–365, 1995. 47 Ritt DJ, Whelan G., Werner DJ, Eigenbrodt EH, Schenker S., Combes B.: Acute hepatic necrosis with stupor or coma: An analysis of thirty-one patients. Medicine 48: 151–172, 1969. 48 Ring-Larsen H., Clausen E., Ranek L.: Peritoneal dialysis in hyponatremia due to liver failure. Scand J Gastroenterol 8: 33–40, 1973. 49 Jacobson S., Bell B.: Recognition and management of acute and chronic hepatic encephalopathy. Med Clin N Am 57: 1569–1577, 1973. 50 Wilkinson SP, Weston MJ, Parsons V., Williams R.: Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8: 287–292, 1977. 51 Epstein M.: Hepatorenal syndrome, in The Kidney in Liver Disease ( 4th ed), edited by M. Epstein New York , Elsevier, 1996, pp. 75–108. 52 Perez G., Golper TA, Epstein M., Oster JR: Dialysis, hemofiltration and other extracorporeal techniques in the treatment of renal complication of liver disease, in The Kidney in Liver Disease ( 4th ed), edited by M. Epstein New York , Elsevier, 1996, pp. 517–528. 53 Topchiashvili ZA, Sergienko VS: Hemodialysis in hepatorenal insufficiency. Khirurgiia 47: 14–16, 1971. 54 Klinger EL, Jr., Cronin RJ: Renal failure in cirrhosis of the liver: Observations during intermittent hemodialysis. Abstracts of the Am Soc Artif Intern Organs, pp. 18–26, 1972. 55 Coratelli P., Passavanti G., Muno I., Fumarola D., Amerio A.: New trends in hepatorenal syndrome. Kidney Int 28 (Suppl 17): S143–S147, 1985. 56 Ellis D., Avner ED: Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. Clin Nephrol 25: 295–303, 1986. 57 Strand V., Mayor G., Ristow G., Greenbaum D., Mayle J., Rosenbaum R.: Concomitant renal and hepatic failure treated by polyacrylonitrile membrane hemodialysis. Int J Artif Organs 4: 136–139, 1981. 58 Keller F., Wagner K., Lenz T., Pommer W., Hahn G., Molzahn M., Krause PH: Hemodialysis in hepatorenal syndrome: Report on two cases. Gut 26: 208–211, 1985. 59 Kearns PJ, Polhemus RJ, Oakes D., Rabkin R.: Hepatorenal syndrome managed with hemodialysis then reversed by peritoneovenous shunting. J Clin Gastroenterol 7: 341–343, 1985. 60 Landini S., Coli U., Lucatello S., Fracasso A., Morachiello P., Toffoletto P., Bazzato G.: Plasma exchange and dialysis: Combined treatment in acute renal insufficiency secondary to severe hepatopathies. Minerva Nefrol 28: 179–186, 1981. 61 Keller F., Heinze H., Jochimsen F., PaBfall J., Schuppan D., Buttner P.: Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with the hepatorenal syndrome): The role of dialysis. Ren Fail 17: 135–146, 1995. 62 Seu P., Wilkinson AH, Shaked A., Busuttil RW: The hepatorenal syndrome in liver transplant recipients. Am Surg 57: 806–809, 1991. 63 Haller M., Schonfeldler R., Briegel J., Pratschke E., Spengler U., Pfeiffer M., Forst H., Finsterer UI: Renal function in the postoperative period after orthotopic liver transplantation. Transplant Proc 24: 2704–2706, 1992. 64 Davenport A., Will EJ, Davidson AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 21: 328–338, 1993. 65 Rowell LB, Evans TO, Kennedy JW, Blackmon JR, Kusumi F.: Splanchnic removal of lactate and pryruvate during prolonged exercise in man. J Appl Physiol 21: 1773–1783, 1966. 66 Davenport A., Will EJ, Davison AM: The effect of lactate-buffered solutions on the acid-base status of patients with renal failure. Nephrol Dial Transplant 4: 800–804, 1989. 67 Davenport A., Aulton K., Payne RB, Will EJ: Hyperlactatemia and increasing metabolic acidosis in hepatorenal failure treated by hemofiltration. Ren Fail 12: 99–101, 1990. 68 Sigler MH, Teehan BP: Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int 32: 562–571, 1987. 69 Conger JD: Does hemodialysis delay recovery from acute renal failure. Semin Dial 3: 146–148, 1990. 70 Schulman G., Fogo A., Gung A., Badr K., Hakim R.: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40: 1069–1074, 1986. 71 Schiff H., Lang SM, Konig A., Strasser T., Haider MC, Held E.: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344: 570–572, 1994. 72 Hakim RM, Wingard RL, Parker RA: Effect of dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331: 1338–1342, 1994. 73 Manns M., Sigler MH, Teehan BP: Advantages of continuous veno-venous hemodialysis (CVVHD) in acute renal failure. J Am Soc Nephrol 6: 470A, 1995. 74 Sussman NL, Lake JR: Treatment of hepatic failure 1966: Current concepts and progress toward liver dialysis. Am J Kidney Dis 27: 605–621, 1996. 75 Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR: Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 16: 1–7, 1992. 76 Davenport A., Will EJ, Davison AM: Early changes in intracranial pressure during hemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Transplant 5: 192–198, 1990. 77 Traber P., Gaiger D., Blei AT: Brain edema in rabbits with galactosamine-induced fulminant hepatitis: Regional differences and effects on intracranial pressure. Gastroenterology 91: 1347–1356, 1986. 78 Opolon P., Rapin JR, Huguet C.: Hepatic failure coma treated by membrane and hemodialysis. Trans Am Soc Artif Intern Organs 22: 701–710, 1976. 79 Silk DB, Williams R.: Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal hemoperfusion and polyacrylonitrile hemodialysis. Int J Artif Organs 1: 29–33, 1978. 80 Sakai K., Suzuki M., Hirashawa Y., Ichida F.: Artificial hepatic support device with polyacrylonitrite (PAN) membrane with special reference to hemodiafiltration. Nippon Rinsho 40: 890–896, 1982. 81 Opolon P.: Large pore hemodialysis in fulminant hepatic failure, in Artificial Liver Support, edited by C. Bruner, FW. Schmidt New York , Springer Verlag, 1981, pp. 141–146. 82 Mathieu D., Gosselin B., Paris JC, Dautrevaux M., Wattel F.: Hemofiltration continue dans le traitement de l'encephalopathie hepatique. Nouv Press Med 11: 1921–1925, 1982. 83 Arieff AL, Massry SG, Barrientos A., Kleeman CR: Brain water and electrolyte metabolism in uremia: Effects of slow and rapid hemodialysis. Kidney Int 4: 177–187, 1973. 84 Silver SM: Cerebral edema after rapid dialysis is not caused by an increase in brain organic osmolytes. J Am Soc Nephrol 6: 1600–1606, 1995. 85 Almdal T., Schroeder T., Ranek L.: Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver failure. Scand J Gastroenterol 24: 299, 1989. 86 Davenport A., Will EJ, Losowky MS, Swindells S.: Continuous arteriovenous hemofiltration in patients with hepatic encephalopathy and renal failure. BMJ 295: 1028, 1987. 87 Splendiani G., Tancredi M., Daniele M., Giammaria U.: Treatment of acute liver failure with hemodetoxification techniques. Int J Artif Organs 13: 370–374, 1990. 88 Matsubara S., Okabe K., Ouchi K., Miyazaki Y., Yajima Y., Suzuki H., Otsuki M., Matsuno S.: Continuous removal of middle molecule by hemofiltration in patients with acute liver failure. Crit Care Med 18: 1331–1338, 1990. 89 Ogawa R., Kishikawa T., Kudo J., Inaba S., Takamatsu Y., Hirata Y., Yoshimatsu H., Ishibashi H., Taniyama T., Zaitsu A.: Effective continuous hemofiltration and plasma exchange for the treatment of subacute type fulminant hepatic failure. Fukuoka Igaku Zasshi-Fukuoka Acta Medica 83: 338–342, 1992. 90 Matsubara S., Okabe K., Ouchi K., Sato T., Matsuno S.: Temporary metabolic support by extracorporeal blood therapy for liver failure after surgery. ASAIO Trans 34: 266–269, 1988. 91 Davenport A.: Hemofiltration in patients with fulminant hepatic failure. Lancet 338: 1604, 1991. 92 Yoshiba M., Yamada H., Yoshikawa Y., Fushiwara K., Toda G., Oka H., Sanjo T., Yamazaki Z., Idezuki Y., Inoue N.: Hemodiafiltration treatment of deep hepatic coma by protein passing membrane: Case report. Artif Organs 10: 417–419, 1986. 93 Van Brommel EFH, Hessel CJ, Jutte NHPM, Zietse R., Bruining HA, Weimar W.: Cytokine kinetics (TNF-IL-1, IL-6) during continuous hemofiltration: A laboratory and clinical study. Contrib Nephrol 116: 62–75, 1995. 94 Oster JR, Perez GO, Materson BJ, Schiff ER, Vaamonde CA: Exacerbation of hepatic encephalopathy by chronic renal failure: Response to maintenance hemodialysis. Clin Nephrol 9: 254–257, 1978. 95 Zazgornik J., Kreuzer W., Balcke P., Kopsa H., Schmidt P., Marosi L.: Portal hypertension and chronic renal insufficiency: Successful treatment with hemodialysis. Fortschr Memd 26: 407–409, 1981. 96 Seagart MF, Cartier B., Verbanck J.: Recurrent hepatic coma in a chronic hemodialysis patient: Successful treatment by CAPD. Perit Dial Bull 4: 32–34, 1984. 97 William R., Gimson A.: Intensive liver care and management of acute liver failure. Dig Dis Sci 36: 820–826, 1991. 98 Cuevas-Mons V., Millian I., Gavaler JS, Starze TE, Von Thiel DH: Prognostic value of preoperatively obtained clinical and laboratory data survival following orthotopic liver transplantation, Hepatology 6: 922–927, 1986. 99 Brems J., Hiatt JR, Colonna II JO, El-Khoury G., Quinones WJ, Ramming KP, Ziomek S., Busuttil RW: Variables influencing the outcome following orthotopic liver transplantation. Arch Surg 122: 1109–1111, 1987. 100 Sandy D., Charles R., Kozlowski L., Paganini E.: Acute dialytic support in patients with end-stage liver disease awaiting liver transplantation. J Am Soc Nephrol 7: A1070, 1996. 101 Tuman KJ, Spiess BD, McCarthy RJ, Logas WJ, Williams JW, Sankary HN: Effects of continuous arteriovenous hemofiltration on cardiopulmonary abnormalities during anesthesia for orthotopic liver. Anesth Analg 67: 363–369, 1988. 102 Korbert SM, Casey C., Rodby RA, Williams W.: The use of continuous arterio-venous hemofiltration in orthotopic liver transplantation. Clin Nephrol 43: 134–136, 1995. 103 Gonwa T., Nery JR, Husberg BS, Klintmalm GB: Simultaneous liver and renal transplantation in man. Transplant 46: 690–693, 1988. Citing Literature Volume11, Issue5September 1998Pages 308-316 ReferencesRelatedInformation
Referência(s)